miR-186
rnamiR-186 dysregulation after MI associates with adverse myocardial remodeling and long-term mortality risk.
Pathway placement
Cascade stepMyocardial injury (shared endpoint)
Confidencemedium
RationalePredicts long-term mortality post-MI; likely reflects myocardial remodeling and injury burden.
Druggability
Not assessed (no mapped human gene target).
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Whole blood or cell-free plasma
Collection tube
PAXgene/Tempus RNA tube · K2/K3-EDTA (lavender-top)
Method / principle
RT-qPCR (TaqMan) or small-RNA sequencing
Reagent / substrate
Target-specific primers/probe; reverse transcriptase (miRNA: stem-loop RT primer)
Platform
qPCR instrument / NGS
Turnaround · availability
Research / send-out · Research (few LDTs)
Literature evidence(1)
- MiR-223 and MiR-186 Are Associated with Long-Term Mortality after Myocardial Infarction.Biomolecules · 2022 · PMID 36139082 · doi